Global Oncology Radiopharmaceutical Market Research Report 2024
Number of Pages: 129
Category: Healthcare and Medical
Country: Tibet
Format:
Published Date: 14 Jan 2024
Global Sodium Tolyltriazole Market Research Report 2024
This report provides a deep insight into the global Oncology Radiopharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Radiopharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Radiopharmaceutical market in any manner.
Global Oncology Radiopharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus
Market Segmentation (by Type)
Oral Drugs
Intravenous Drugs
Other
Market Segmentation (by Application)
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Oncology Radiopharmaceutical Market
• Overview of the regional outlook of the Oncology Radiopharmaceutical Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
This report provides a deep insight into the global Oncology Radiopharmaceutical market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Radiopharmaceutical Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Radiopharmaceutical market in any manner.
Global Oncology Radiopharmaceutical Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
Chimeric Therapeutics Limited
Fusion Pharma
Lantheus Medical lmaging, Inc.
NanoMab
NuView Life Sciences.
PentixaPharm GmbHPrecirix
RadioMedix
RayzeBio
Telix Pharmaceuticals Limited
Theragnostics Ltd
Vect-Horus
Market Segmentation (by Type)
Oral Drugs
Intravenous Drugs
Other
Market Segmentation (by Application)
Hospitals and Clinics
Pharmaceutical Company
Research Center
Other
Geographic Segmentation
• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Oncology Radiopharmaceutical Market
• Overview of the regional outlook of the Oncology Radiopharmaceutical Market:
Key Reasons to Buy this Report:
• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Radiopharmaceutical Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Oncology Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Oncology Radiopharmaceutical Segment by Type
1.2.2 Oncology Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Radiopharmaceutical Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Radiopharmaceutical Market Competitive Landscape
3.1 Global Oncology Radiopharmaceutical Sales by Manufacturers (2019-2024)
3.2 Global Oncology Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Radiopharmaceutical Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Radiopharmaceutical Sales Sites, Area Served, Product Type
3.6 Oncology Radiopharmaceutical Market Competitive Situation and Trends
3.6.1 Oncology Radiopharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Radiopharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Radiopharmaceutical Industry Chain Analysis
4.1 Oncology Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Radiopharmaceutical Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Radiopharmaceutical Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Radiopharmaceutical Sales Market Share by Type (2019-2024)
6.3 Global Oncology Radiopharmaceutical Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Radiopharmaceutical Price by Type (2019-2024)
7 Oncology Radiopharmaceutical Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Radiopharmaceutical Market Sales by Application (2019-2024)
7.3 Global Oncology Radiopharmaceutical Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Radiopharmaceutical Sales Growth Rate by Application (2019-2024)
8 Oncology Radiopharmaceutical Market Segmentation by Region
8.1 Global Oncology Radiopharmaceutical Sales by Region
8.1.1 Global Oncology Radiopharmaceutical Sales by Region
8.1.2 Global Oncology Radiopharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Radiopharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Radiopharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Radiopharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Radiopharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Radiopharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Oncology Radiopharmaceutical Basic Information
9.1.2 Novartis Oncology Radiopharmaceutical Product Overview
9.1.3 Novartis Oncology Radiopharmaceutical Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Oncology Radiopharmaceutical SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Chimeric Therapeutics Limited
9.2.1 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Basic Information
9.2.2 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Overview
9.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Market Performance
9.2.4 Chimeric Therapeutics Limited Business Overview
9.2.5 Chimeric Therapeutics Limited Oncology Radiopharmaceutical SWOT Analysis
9.2.6 Chimeric Therapeutics Limited Recent Developments
9.3 Fusion Pharma
9.3.1 Fusion Pharma Oncology Radiopharmaceutical Basic Information
9.3.2 Fusion Pharma Oncology Radiopharmaceutical Product Overview
9.3.3 Fusion Pharma Oncology Radiopharmaceutical Product Market Performance
9.3.4 Fusion Pharma Oncology Radiopharmaceutical SWOT Analysis
9.3.5 Fusion Pharma Business Overview
9.3.6 Fusion Pharma Recent Developments
9.4 Lantheus Medical lmaging, Inc.
9.4.1 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Basic Information
9.4.2 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Overview
9.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Market Performance
9.4.4 Lantheus Medical lmaging, Inc. Business Overview
9.4.5 Lantheus Medical lmaging, Inc. Recent Developments
9.5 NanoMab
9.5.1 NanoMab Oncology Radiopharmaceutical Basic Information
9.5.2 NanoMab Oncology Radiopharmaceutical Product Overview
9.5.3 NanoMab Oncology Radiopharmaceutical Product Market Performance
9.5.4 NanoMab Business Overview
9.5.5 NanoMab Recent Developments
9.6 NuView Life Sciences.
9.6.1 NuView Life Sciences. Oncology Radiopharmaceutical Basic Information
9.6.2 NuView Life Sciences. Oncology Radiopharmaceutical Product Overview
9.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product Market Performance
9.6.4 NuView Life Sciences. Business Overview
9.6.5 NuView Life Sciences. Recent Developments
9.7 PentixaPharm GmbHPrecirix
9.7.1 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Basic Information
9.7.2 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Overview
9.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Market Performance
9.7.4 PentixaPharm GmbHPrecirix Business Overview
9.7.5 PentixaPharm GmbHPrecirix Recent Developments
9.8 RadioMedix
9.8.1 RadioMedix Oncology Radiopharmaceutical Basic Information
9.8.2 RadioMedix Oncology Radiopharmaceutical Product Overview
9.8.3 RadioMedix Oncology Radiopharmaceutical Product Market Performance
9.8.4 RadioMedix Business Overview
9.8.5 RadioMedix Recent Developments
9.9 RayzeBio
9.9.1 RayzeBio Oncology Radiopharmaceutical Basic Information
9.9.2 RayzeBio Oncology Radiopharmaceutical Product Overview
9.9.3 RayzeBio Oncology Radiopharmaceutical Product Market Performance
9.9.4 RayzeBio Business Overview
9.9.5 RayzeBio Recent Developments
9.10 Telix Pharmaceuticals Limited
9.10.1 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Basic Information
9.10.2 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Overview
9.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Market Performance
9.10.4 Telix Pharmaceuticals Limited Business Overview
9.10.5 Telix Pharmaceuticals Limited Recent Developments
9.11 Theragnostics Ltd
9.11.1 Theragnostics Ltd Oncology Radiopharmaceutical Basic Information
9.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Product Overview
9.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product Market Performance
9.11.4 Theragnostics Ltd Business Overview
9.11.5 Theragnostics Ltd Recent Developments
9.12 Vect-Horus
9.12.1 Vect-Horus Oncology Radiopharmaceutical Basic Information
9.12.2 Vect-Horus Oncology Radiopharmaceutical Product Overview
9.12.3 Vect-Horus Oncology Radiopharmaceutical Product Market Performance
9.12.4 Vect-Horus Business Overview
9.12.5 Vect-Horus Recent Developments
10 Oncology Radiopharmaceutical Market Forecast by Region
10.1 Global Oncology Radiopharmaceutical Market Size Forecast
10.2 Global Oncology Radiopharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Radiopharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Radiopharmaceutical Market Size Forecast by Region
10.2.4 South America Oncology Radiopharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Radiopharmaceutical by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology Radiopharmaceutical Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Radiopharmaceutical by Type (2025-2030)
11.1.2 Global Oncology Radiopharmaceutical Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Radiopharmaceutical by Type (2025-2030)
11.2 Global Oncology Radiopharmaceutical Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Radiopharmaceutical Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Radiopharmaceutical Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
1.1 Market Definition and Statistical Scope of Oncology Radiopharmaceutical
1.2 Key Market Segments
1.2.1 Oncology Radiopharmaceutical Segment by Type
1.2.2 Oncology Radiopharmaceutical Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Oncology Radiopharmaceutical Market Overview
2.1 Global Market Overview
2.1.1 Global Oncology Radiopharmaceutical Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Radiopharmaceutical Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Oncology Radiopharmaceutical Market Competitive Landscape
3.1 Global Oncology Radiopharmaceutical Sales by Manufacturers (2019-2024)
3.2 Global Oncology Radiopharmaceutical Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Radiopharmaceutical Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Radiopharmaceutical Sales Sites, Area Served, Product Type
3.6 Oncology Radiopharmaceutical Market Competitive Situation and Trends
3.6.1 Oncology Radiopharmaceutical Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Radiopharmaceutical Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Oncology Radiopharmaceutical Industry Chain Analysis
4.1 Oncology Radiopharmaceutical Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Oncology Radiopharmaceutical Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Oncology Radiopharmaceutical Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Radiopharmaceutical Sales Market Share by Type (2019-2024)
6.3 Global Oncology Radiopharmaceutical Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Radiopharmaceutical Price by Type (2019-2024)
7 Oncology Radiopharmaceutical Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Radiopharmaceutical Market Sales by Application (2019-2024)
7.3 Global Oncology Radiopharmaceutical Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Radiopharmaceutical Sales Growth Rate by Application (2019-2024)
8 Oncology Radiopharmaceutical Market Segmentation by Region
8.1 Global Oncology Radiopharmaceutical Sales by Region
8.1.1 Global Oncology Radiopharmaceutical Sales by Region
8.1.2 Global Oncology Radiopharmaceutical Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Radiopharmaceutical Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Radiopharmaceutical Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Radiopharmaceutical Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Radiopharmaceutical Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Radiopharmaceutical Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Oncology Radiopharmaceutical Basic Information
9.1.2 Novartis Oncology Radiopharmaceutical Product Overview
9.1.3 Novartis Oncology Radiopharmaceutical Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Oncology Radiopharmaceutical SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Chimeric Therapeutics Limited
9.2.1 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Basic Information
9.2.2 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Overview
9.2.3 Chimeric Therapeutics Limited Oncology Radiopharmaceutical Product Market Performance
9.2.4 Chimeric Therapeutics Limited Business Overview
9.2.5 Chimeric Therapeutics Limited Oncology Radiopharmaceutical SWOT Analysis
9.2.6 Chimeric Therapeutics Limited Recent Developments
9.3 Fusion Pharma
9.3.1 Fusion Pharma Oncology Radiopharmaceutical Basic Information
9.3.2 Fusion Pharma Oncology Radiopharmaceutical Product Overview
9.3.3 Fusion Pharma Oncology Radiopharmaceutical Product Market Performance
9.3.4 Fusion Pharma Oncology Radiopharmaceutical SWOT Analysis
9.3.5 Fusion Pharma Business Overview
9.3.6 Fusion Pharma Recent Developments
9.4 Lantheus Medical lmaging, Inc.
9.4.1 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Basic Information
9.4.2 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Overview
9.4.3 Lantheus Medical lmaging, Inc. Oncology Radiopharmaceutical Product Market Performance
9.4.4 Lantheus Medical lmaging, Inc. Business Overview
9.4.5 Lantheus Medical lmaging, Inc. Recent Developments
9.5 NanoMab
9.5.1 NanoMab Oncology Radiopharmaceutical Basic Information
9.5.2 NanoMab Oncology Radiopharmaceutical Product Overview
9.5.3 NanoMab Oncology Radiopharmaceutical Product Market Performance
9.5.4 NanoMab Business Overview
9.5.5 NanoMab Recent Developments
9.6 NuView Life Sciences.
9.6.1 NuView Life Sciences. Oncology Radiopharmaceutical Basic Information
9.6.2 NuView Life Sciences. Oncology Radiopharmaceutical Product Overview
9.6.3 NuView Life Sciences. Oncology Radiopharmaceutical Product Market Performance
9.6.4 NuView Life Sciences. Business Overview
9.6.5 NuView Life Sciences. Recent Developments
9.7 PentixaPharm GmbHPrecirix
9.7.1 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Basic Information
9.7.2 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Overview
9.7.3 PentixaPharm GmbHPrecirix Oncology Radiopharmaceutical Product Market Performance
9.7.4 PentixaPharm GmbHPrecirix Business Overview
9.7.5 PentixaPharm GmbHPrecirix Recent Developments
9.8 RadioMedix
9.8.1 RadioMedix Oncology Radiopharmaceutical Basic Information
9.8.2 RadioMedix Oncology Radiopharmaceutical Product Overview
9.8.3 RadioMedix Oncology Radiopharmaceutical Product Market Performance
9.8.4 RadioMedix Business Overview
9.8.5 RadioMedix Recent Developments
9.9 RayzeBio
9.9.1 RayzeBio Oncology Radiopharmaceutical Basic Information
9.9.2 RayzeBio Oncology Radiopharmaceutical Product Overview
9.9.3 RayzeBio Oncology Radiopharmaceutical Product Market Performance
9.9.4 RayzeBio Business Overview
9.9.5 RayzeBio Recent Developments
9.10 Telix Pharmaceuticals Limited
9.10.1 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Basic Information
9.10.2 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Overview
9.10.3 Telix Pharmaceuticals Limited Oncology Radiopharmaceutical Product Market Performance
9.10.4 Telix Pharmaceuticals Limited Business Overview
9.10.5 Telix Pharmaceuticals Limited Recent Developments
9.11 Theragnostics Ltd
9.11.1 Theragnostics Ltd Oncology Radiopharmaceutical Basic Information
9.11.2 Theragnostics Ltd Oncology Radiopharmaceutical Product Overview
9.11.3 Theragnostics Ltd Oncology Radiopharmaceutical Product Market Performance
9.11.4 Theragnostics Ltd Business Overview
9.11.5 Theragnostics Ltd Recent Developments
9.12 Vect-Horus
9.12.1 Vect-Horus Oncology Radiopharmaceutical Basic Information
9.12.2 Vect-Horus Oncology Radiopharmaceutical Product Overview
9.12.3 Vect-Horus Oncology Radiopharmaceutical Product Market Performance
9.12.4 Vect-Horus Business Overview
9.12.5 Vect-Horus Recent Developments
10 Oncology Radiopharmaceutical Market Forecast by Region
10.1 Global Oncology Radiopharmaceutical Market Size Forecast
10.2 Global Oncology Radiopharmaceutical Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Radiopharmaceutical Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Radiopharmaceutical Market Size Forecast by Region
10.2.4 South America Oncology Radiopharmaceutical Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Radiopharmaceutical by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Oncology Radiopharmaceutical Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Radiopharmaceutical by Type (2025-2030)
11.1.2 Global Oncology Radiopharmaceutical Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Radiopharmaceutical by Type (2025-2030)
11.2 Global Oncology Radiopharmaceutical Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Radiopharmaceutical Sales (Kilotons) Forecast by Application
11.2.2 Global Oncology Radiopharmaceutical Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings